Electronic Schizophrenia Treatment Adherence Registry.

Trial Profile

Electronic Schizophrenia Treatment Adherence Registry.

Phase of Trial: Phase IV

Latest Information Update: 26 Apr 2012

At a glance

  • Drugs Risperidone (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 26 Apr 2012 Actual patient number is 408 according to ClinicalTrials.gov.
    • 11 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top